Bifurcation Lesions Market Forecast 2025-2034: Comprehensive Insights on Market Size, Growth Factors, Trends

June 06, 2025 03:48 AM AEST | By EIN Presswire
 Bifurcation Lesions Market Forecast 2025-2034: Comprehensive Insights on Market Size, Growth Factors, Trends
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /EINPresswire.com/ -- What Is The Projected Market Size Of The Bifurcation Lesions Market?
The bifurcation lesions market has seen substantial growth in recent years and is anticipated to continue its positive trajectory through the next few years. There has been a rise from $2.63 billion in 2024 to an impressive $2.86 billion in 2025, reflecting a compound annual growth rate CAGR of 8.5%. This growth can be attributed to the rise in the prevalence of coronary artery diseases, increased geriatric population, healthcare expenditure, and economic growth.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7414&type=smp

What Are The Key Growth Drivers Of The Bifurcation Lesions Market?
The surge in the geriatric population is expected to be a key growth driver for the bifurcation lesions market. Older individuals, particularly those aged over 60 years are more susceptible to heart conditions including heart attacks, strokes, coronary heart disease, and heart failures. Bifurcation lesions have a vital role in treating these blood clots and ensuring adequate blood flow to the heart. An interesting report by the World Health Organisation predicted that by 2030, one in six people will be over 60 years of age. By the year 2050, the number of people aged 60 years or older will rise to 2.1 billion. Consequently, the rising elderly population is anticipated to drive the bifurcation lesions market growth.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/bifurcation-lesions-global-market-report

What Can We Predict About The Bifurcation Lesions Market Size In The Future?
The market size for bifurcation lesions is projected to rise to $4.02 billion by 2029 bearing a compound annual growth rate CAGR of 8.9%. The expansion of healthcare infrastructure, escalating demand for minimally invasive surgeries, increasing prevalence of cardiovascular diseases, and government healthcare policies could be key contributors to this growth. The expected trends for the forecast period include patient-centric approaches, bioresorbable stents, integration of artificial intelligence and machine learning, and cross-specialty collaboration.

Who Are The Key Industry Players In The Bifurcation Lesions Market?
Major players operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, and others.

Do We Foresee Any Emerging Trends in the Bifurcation Lesions Market?
Recent advancements in the devices used in imaging and procedures are a significant trend in the bifurcation lesions market. Companies are channeling their efforts into innovating existing devices. For example, Advanced Bifurcation Systems ABS, a clinical-stage medical device firm, has developed a unique bifurcation stenting solution for coronary angioplasties. Their platform features a unique modular self-aligning stent technology facilitating even bifurcations. This reduces the need for repeat procedures and ensures effective treatment.

How Is The Bifurcation Lesions Market Segmented?
The bifurcation lesions market segmentation include:
1. By Types: One-Stent, Two-Stent
2. By Application: Coronary Vascular, Peripheral vascular

Further, the subsegmentations are:
1. By One-Stent: Single-Stent Deployment, Balloon-Expandable Stents, Self-Expanding Stents
2. By Two-Stent: Crush Technique, T- or Y-Configuration Stenting, Side Branch Stenting Techniques

What Regional Insights Can We Observe?
In 2024, North America dominated the bifurcation lesions market. However, Asia-Pacific is predicted to be the fastest-growing region in the forecast period. Regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Bioabsorbable Stents Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

Vascular Grafts Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report

Anticoagulants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

About The Business Research Company:
The Business Research Company is known for its extensive research, offering data-rich research and insights. The company boasts over 15000+ reports from 27 industries covering 60+ geographies. The optimistic contribution of in-depth secondary research and unique insights from industry leaders helps you stay ahead of the curve.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.